Aegerion Pharma (AEGR) Posts Q2 Loss of 49c, Misses Views
Tweet Send to a FriendGet Alerts AEGR Hot Sheet
Trade AEGR Now!
Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) reported Q2 EPS of ($0.49), $0.09 worse than the analyst estimate of ($0.40).
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Orient Paper, Inc. (ONP) Reports Q1 EPS of $0.02; Guides FY13
- Brady Corp. (BRC) Misses Q3 EPS by 5c; Guides Q4 EPS Below Views
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
